← Back to Search

Tissue Adhesive

Skin Glue vs Sutures for Cesarean Section Closure

N/A
Recruiting
Led By Russell Miller, MD
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up intraoperative
Awards & highlights

Study Summary

This trial compares two methods of closing a Cesarean section incision to see which is better.

Who is the study for?
This trial is for women aged 18 or older who are scheduled for their first or subsequent cesarean deliveries, whether during labor or before it starts. They must be having a Pfannenstiel skin incision and giving birth to a live infant at the time of cesarean delivery.Check my eligibility
What is being tested?
The study compares two methods of closing incisions after cesarean sections: using Dermabond Prineo system versus standard subcuticular sutures (stitches under the skin). The goal is to see which method leads to better healing outcomes.See study design
What are the potential side effects?
Possible side effects may include allergic reactions to adhesive in Dermabond Prineo, infection, pain at the incision site, poor wound healing, and scarring. Suture might cause discomfort, inflammation or also lead to infection.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~intraoperative
This trial's timeline: 3 weeks for screening, Varies for treatment, and intraoperative for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Patient scar satisfaction
Secondary outcome measures
Incidence of surgical site infection (SSI)
Operative time
Skin closure time

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Dermabond Prineo GroupActive Control1 Intervention
At time of cesarean delivery, patients in the Dermabond Prineo group will undergo skin closure with the Dermabond Prineo skin adhesive system.
Group II: Suture GroupPlacebo Group1 Intervention
At time of cesarean delivery, patients in the Suture group will undergo skin closure with standard subcuticular suture.

Find a Location

Who is running the clinical trial?

Columbia UniversityLead Sponsor
1,431 Previous Clinical Trials
2,460,643 Total Patients Enrolled
Russell Miller, MDPrincipal InvestigatorColumbia University
1 Previous Clinical Trials
24 Total Patients Enrolled

Media Library

Dermabond Prineo (Tissue Adhesive) Clinical Trial Eligibility Overview. Trial Name: NCT05903547 — N/A
Cesarean Section Research Study Groups: Dermabond Prineo Group, Suture Group
Cesarean Section Clinical Trial 2023: Dermabond Prineo Highlights & Side Effects. Trial Name: NCT05903547 — N/A
Dermabond Prineo (Tissue Adhesive) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05903547 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still vacancies for prospective participants in this investigation?

"According to information on clinicaltrials.gov, this research project is presently not recruiting patients; it was posted in June of 2023 and last updated a few days later. However, 65 other trials are actively seeking participants at the moment."

Answered by AI
~113 spots leftby Apr 2025